|Research Scientist-RNA Platform Eng|
|Elanco is a global animal health company that develops products and knowledge services to prevent and treat disease in food animals and pets in more than 90 countries. With a 64-year heritage, we rigorously innovate to improve the health of animals and benefit our customers, while fostering an inclusive, cause-driven culture for more than 5,800 employees. At Elanco, we’re driven by our vision of food and companionship enriching life – all to advance the health of animals, people and the planet. Learn more at www.elanco.com|
The Research Scientist is responsible for leveraging contemporary tools in molecular and synthetic biology to conduct basic and applied research as an individual contributor in the Elanco Research Labs and the Discovery Virology group. This position will be particularly tasked with enabling RNA-based vaccine platforms. A strong foundation in molecular biology, synthetic biology, and protein biochemistry techniques, coupled with practical experience in molecular virology, will be required to proactively search for solutions in this discovery driven team. The ability to independently conceptualize and execute experiments, coupled with a “can do” attitude, is essential. The incumbent will spend the majority of their time designing and executing experiments in several different spaces, including RNA vaccine engineering, rational antigen design, recombinant viral vaccines, viral vectors, host target identification and validation, and novel approaches to vaccinology.
|Elanco is an EEO/Affirmative Action Employer and does not discriminate on the basis of age, race, color, religion, gender, sexual orientation, gender identity, gender expression, national origin, protected veteran status, disability or any other legally protected status.|
Location & Expected Travel Percentage:
Greenfield, IN. Occasional (5-10%) travel (mainly US).